Qin Dan, Zhang He, Du Bin, Wang Hui, Liu Ligang, Wang Yun
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
Department of Pharmacy, Medical Supplies Center of Chinese PLA General Hospital, Beijing, China.
Front Pharmacol. 2025 May 12;16:1551531. doi: 10.3389/fphar.2025.1551531. eCollection 2025.
Ancient classic and famous prescriptions (ACFPs), derived from traditional Chinese medicine (TCM) classics, are widely utilized due to their precise therapeutic effects and distinctive clinical advantages. Existing research predominantly focuses on individual prescriptions, and there is lack of systematic exploration of medication patterns within the official ACFPs catalog. The property of Chinese materia medica (PCMM), a multidimensional representation of medicinal properties, offers a novel perspective for systematically analyzing TCM formulas.
In this study, we aim to investigate the implicit medication patterns of ACFPs from the PCMM perspective, establish a feature extraction model based on the property combination of Chinese materia medica (PCCMM), and evaluate its effectiveness in representing and reconstructing ACFPs.
Based on the Chinese Pharmacopoeia (ChP), we constructed a CMM-PCCMM network as the forward feature extraction process. We formulated the backward process as a constrained combinatorial optimization problem to rebuild ACFPs from their PCCMMs. We evaluated the performance of PCCMM in reconstructing ACFPs using the Jaccard similarity coefficient. Furthermore, we tested the capability of PCCMM to distinguish ACFPs from random pseudo-formulas and classify ACFPs according to deficiency syndromes. Finally, we conducted frequency analysis, association rule analysis, distance analysis, and correlation analysis to explore the implicit medication patterns of ACFPs based on PCCMM.
Numerical experiments showed that PCCMM effectively represented and reconstructed ACFPs, achieving an average Jaccard similarity coefficient above 0.8. PCCMM outperformed the nomenclature of CMM in distinguishing ACFPs from random pseudo-formulas and classifying deficiency syndromes. Frequency analysis revealed that high-frequency CMMs were mainly tonic medicines, whereas high-frequency PCCMMs predominantly mapped to the even-sweet-spleen meridian. The association rule analysis based on PCCMM yielded significantly more implicit compatibility rules than CMM alone. Distance and correlation analyses identified synergistic CMM pairs and PCCMM pairs, such as (Dazao) and (Shengjiang), which is consistent with clinical experience.
The PCCMM-based feature extraction model provides a quasi-equivalent representation of TCM formulas, effectively capturing implicit medication patterns within ACFPs. PCCMM outperforms traditional CMM methods in formula reconstruction, classification, and medication pattern mining. This study offers novel insights and methodologies for systematically understanding TCM formulas, guiding clinical application, and facilitating the design and optimization of new TCM formulas.
源自中医经典的古代经典名方,因其确切的治疗效果和独特的临床优势而被广泛应用。现有研究主要集中在单个方剂上,缺乏对官方经典名方目录中用药模式的系统探索。中药药性是药物性质的多维表征,为系统分析中药方剂提供了新的视角。
本研究旨在从中药药性角度探究经典名方的隐含用药模式,建立基于中药药性组合的特征提取模型(PCCMM),并评估其在表示和重构经典名方方面的有效性。
基于《中国药典》构建中药-中药药性组合网络作为正向特征提取过程。将反向过程表述为约束组合优化问题,以便从其药性组合中重建经典名方。我们使用杰卡德相似系数评估药性组合在重构经典名方方面的性能。此外,我们测试了药性组合区分经典名方与随机伪方以及根据虚证对经典名方进行分类的能力。最后,我们进行频率分析、关联规则分析、距离分析和相关性分析,以基于药性组合探索经典名方的隐含用药模式。
数值实验表明,药性组合有效地表示和重构了经典名方,平均杰卡德相似系数超过0.8。在区分经典名方与随机伪方以及对虚证进行分类方面,药性组合优于中药名称。频率分析表明,高频中药主要是滋补药,而高频药性组合主要对应于足太阴脾经。基于药性组合的关联规则分析产生的隐含配伍规则比单独的中药显著更多。距离和相关性分析确定了协同的中药对和药性组合对,如(大枣)和(生姜),这与临床经验一致。
基于药性组合构建的特征提取模型为中药方剂提供了近似等效的表示,有效捕捉了经典名方中的隐含用药模式。在方剂重构、分类和用药模式挖掘方面,药性组合优于传统的中药方法。本研究为系统理解中药方剂、指导临床应用以及促进新中药方剂的设计和优化提供了新的见解和方法。